- Titre
- BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer
- Créateurs - sans rôle
- William Jacot - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceSimon Thezenas - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceRomain Senal - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceCathy Viglianti - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceAnne-Claire Laberenne - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceEvelyne Lopez-Crapez - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceFrédéric Bibeau - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceJean-Pierre Bleuse - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FranceGilles Romieu - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, FrancePierre-Jean Lamy - Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France Translational Research Unit, Montpellier Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier Cedex 5, France Department of Biostatistics, Montpellier Cancer Institute, Montpellier, France Department of Biology and Oncogenetic, Montpellier Cancer Institute, Montpellier, France Department of Pathology, Montpellier Cancer Institute, Montpellier, France
- Détails de publication
- BMC cancer, Vol.13(1), pp.523-523
- Éditeur
- BioMed Central
- Nombre de pages
- 1
- Identifiants
- 99140125009311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer
BMC cancer, Vol.13(1), pp.523-523
05/11/2013
PMID: 24191908
Indicateurs
1 Consultations de la notice